
Genesis Molecular AI offers an AI operating system, GEMS, that designs and optimizes small-molecule drug candidates to accelerate discovery for biopharmaceutical companies. The company combines…

Genesis Molecular AI offers an AI operating system, GEMS, that designs and optimizes small-molecule drug candidates to accelerate discovery for biopharmaceutical companies. The company combines…
Principal / Senior ADME Scientist - San Diego, CA Genesis Molecular AI is pioneering artificial intelligence–guided rational drug design to address severe unmet medical needs. Our San Diego laboratory is seeking a motivated and versatile ADME Scientist to join our Non-Clinical Development team and help advance our compounds through preclinical and clinical development. The successful candidate will contribute to drug discovery and development through the execution of DMPK assays and related studies.
This is a full-time position in a fast-paced biotech environment with a collaborative team of highly skilled colleagues working toward well-defined scientific and development goals. The role offers comprehensive medical and dental benefits, flexible work hours, and vacation time, along with the opportunity to gain broad exposure to the operations of a biotechnology start-up.
The ideal candidate for this Sr. Scientist/Principal Scientist role will have expertise in a variety of ADME related assays (metabolic stability, protein binding, drug-drug interactions, etc.) They will be able to develop, perform and troubleshoot assays internally as well as oversee and manage outsourced work. They will serve as the subject matter expert in the in-vitro ADME space, providing strategic input to the project teams. Experience with bioanalytical assays and method development is preferred.
Learn more about us here: https://genesis.ml/
What You Will Do
What You Will Bring
About Genesis Molecular AI Genesis Molecular AI is pioneering foundation models for molecular AI to unlock a new era of drug design and development. The company’s generative and predictive AI platform, GEMS (Genesis Exploration of Molecular Space), integrates AI and physics into industry-leading models to generate and optimize drug molecules, including the breakthrough generative diffusion model Pearl for structure prediction. Genesis has raised over $300 million from leading AI, tech and life science-focused investors, signed multiple AI-focused research collaborations with major pharma partners, and is deploying GEMS to advance an internal therapeutics pipeline for a variety of high-impact targets.
Genesis is headquartered in San Mateo, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,200+
New This Week